Fingerprint
Dive into the research topics of 'Durable responses after ibritumomab tiuxetan radioimmunotherapy for CD20+ B-cell lymphoma: Long-term follow-up of a phase 1/2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically